BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Big Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2276.64 only $1138.32

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      71.98
      -0.08%
      Bitcoin
      96,670.13
      -0.84%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Corcept Therapeutics Inc (CORT)

      7. Corcept Therapeutics Inc (CORT) Financials

      Corcept Therapeutics Inc

      Corcept Therapeutics Inc (CORT)

      NASDAQ
      57.68
      -0.92
      (-1.57%)
      Closed November 30 4:00PM
      Delayed by 15 minutes
      57.68
      0.00
      (0.00%)
      After Hours: 4:33PM
      Delayed by 15 minutes

      Corcept Therapeutics Inc Financial Summary

      The current CORT market cap is 6.04B. The company's latest EPS is USD 1.0130 and P/E is 56.94.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 123.6M135.41M146.81M163.8M182.55M
      Operating Income 31.18M31.67M29.5M35.59M46.6M
      Net Income 31.38M31.36M27.76M35.49M47.21M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 306.49M353.87M365.98M401.86M482.38M
      Operating Income 111.61M128.2M124.48M98.63M107.28M
      Net Income 94.18M106.01M112.51M101.42M106.14M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 594.02M621.52M655.94M714.56M784.26M
      Total Liabilities 132.34M114.81M108.07M118.31M145.42M
      Total Equity 461.68M506.71M547.86M596.24M638.84M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 412.31M571.73M423.76M583.43M621.52M
      Total Liabilities 41.13M48.39M47.95M81.59M114.81M
      Total Equity 371.18M523.34M375.81M501.84M506.71M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 121.15M127.04M23.76M64.94M138.77M
      Investing 73.81M90.91M-9.01M-69.21M-113.24M
      Financing -149.49M-148.72M-543k-2.69M-23.79M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 136.12M151.97M167.89M120.32M127.04M
      Investing -117.83M-119.26M136.13M-114.33M90.91M
      Financing -28.65M12.21M-302.59M-17.28M-148.72M

      Stats and Ratios

      Market Cap 6.04B
      Price to Earnings Ratio 56.94
      Price to Sales Ratio 12.53
      Price to Cash Ratio 44.59
      Price to Book Ratio 11.93
      Dividend Yield -

      Share Statistics

      Shares Outstanding 104.78M
      Average Volume (1 week) 853.4k
      Average Volume (1 Month) 1.01M
      52 Week Change 125.22%
      52 Week High 61.663
      52 Week Low 20.84
      Spread (Intraday) 0.5 (0.86%)

      Company Info

      Company Name Corcept Therapeutics Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.corcept.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      CORT
      Corcept Therapeutics
      Delayed Upgrade Clock